Adverse events during treatment with high-dose intravenous immunoglobulins for neurological disorders

European Neurology

Volumn 40, Issue 3, 1998, Pages 173-174

  Stangel, Martin ^a,b   Müller, Markus ^a   Marx, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEMOGLOBIN; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN 7S; LIVER ENZYME;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BACKACHE; CHILL; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DEMYELINATING NEUROPATHY; ENCEPHALITIS; ERYTHROCYTE COUNT; FEMALE; GUILLAIN BARRE SYNDROME; HEADACHE; HEMATOCRIT; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHERMIA; INFUSION; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY; LUMBAR PUNCTURE; MALAISE; MALE; MEDICAL RECORD; MOTOR NEUROPATHY; NAUSEA; NEUROLOGIC DISEASE; PAIN; PRIORITY JOURNAL; PRURITUS; RASH; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; SWEATING; VOMITING;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; RETROSPECTIVE STUDIES;

EID: 0031663534     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007976     Document Type: Article

References (9)

1. van der Meché FGA, van Doom PA: The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders. Muscle Nerve 1997;20:136-147.
2. Stangel M, Hartung H-P, Marx P, Gold R: Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 1998;153: 203-214.
3. Duhem C, Dicato MA, Ries F: Side-effects of intravenous immune globulins. Clin Exp Immunol 1994;97(suppl 1):79-83.
4. Ratko TA, Burnett DA, Foulke GE, Matuszewski KA, Sacher RA, University consortium expert panel: Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 1995;273: 1865-1870.
5. Brannagan TH, Nagle KJ, Lange DJ, Rowland LP: Complications of intravenous immune globulin treatment in neurologic disease. Neurology 1996; 47:674-677.
6. Bertorini TE, Nance AM, Homer LH, Greene W, Gelfand MS, Jaster JH: Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 1996;19:388-391.
7. Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A: Pain in Guillain-Barré syndrome. Neurology 1997;48:328-331.
8. Wilson JR, Bhoopalam N, Fisher M: Haemolytic anemia associated with intravenous immunoglobulin. Muscle Nerve 1997;20:1142-1145.
9. Domes PG, van der Meché FGA, Kleyweg RP, Dutch Guillain-Barré Study Group: Liver function disturbances in Guillain-Barré syndrome: A prospective longitudinal study in 100 patients. Neurology 1996;46:96-100.